ABL Bio Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Sang Hoon Lee

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.8yrs
CEO ownership27.6%
Management average tenure2.8yrs
Board average tenureno data

Recent management updates

No updates

Recent updates

Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?

May 29
Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?

Is ABL Bio (KOSDAQ:298380) Weighed On By Its Debt Load?

Feb 26
Is ABL Bio (KOSDAQ:298380) Weighed On By Its Debt Load?

We Think ABL Bio (KOSDAQ:298380) Can Afford To Drive Business Growth

Mar 31
We Think ABL Bio (KOSDAQ:298380) Can Afford To Drive Business Growth

Should ABL Bio (KOSDAQ:298380) Be Disappointed With Their 33% Profit?

Jan 20
Should ABL Bio (KOSDAQ:298380) Be Disappointed With Their 33% Profit?

Companies Like ABL Bio (KOSDAQ:298380) Are In A Position To Invest In Growth

Dec 16
Companies Like ABL Bio (KOSDAQ:298380) Are In A Position To Invest In Growth

CEO

Sang Hoon Lee

8.8yrs

Tenure

Dr. Sang Hoon Lee, PH D co-founded PharmAbcine, Inc. in 2008 and serves as its Executive Vice President. Dr. Lee founded ABL Bio Inc. in February 2016 and serves as its President and Chief Executive Office...


Leadership Team

NamePositionTenureCompensationOwnership
Sang Hoon Lee
Founder8.8yrsno data27.56%
₩ 511.9b
Jaecheon Lee
Executive VPno datano data1.55%
₩ 28.9b
Jung Dae Kim
Executive VP & COOno datano datano data
You Weon-Kyoo
Executive VP2.8yrsno data1.43%
₩ 26.6b
Jaeho Jung
Executive VP & Chief of Discoveryno datano data0%
₩ 0
Jong Hwa Won
Executive VPno datano datano data
Eunkyung Kim
Head of Medical & Clinical Development2.8yrsno datano data

2.8yrs

Average Tenure

Experienced Management: A298380's management team is considered experienced (2.8 years average tenure).